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Fritsch and Bobbitt Named NAI Fellows
The National Academy of Inventors (NAI) has named 170 distinguished innovators to NAI Fellow status, increasing the total number
of NAI Fellows to 414. The NAI Fellows will be inducted on March 20,
2015, as part of the 4th Annual Conference of the National Academy of
Inventors at the California Institute of Technology in Pasadena, CA.
U.S. Patent and Trademark Office (USPTO) Deputy Commissioner for
Patent Operations Andrew Faile will be providing the keynote address
for the induction ceremony. Fellows will be presented with a special
trophy, newly designed medal, and rosette pin in honor of their outstanding accomplishments.
The department is proud of the fact that one of its own, Dr.
Ingrid Fritsch, was named an NAI Fellow. Says Fritsch, “I’m delighted
to be named a fellow of the National Academy of Inventors. This
recognition validates my vision and efforts toward building up the science and technology base in Arkansas in association with the area’s scientific and business community with meaningful impact on the world. Scientific advances do not take place in a vacuum. They
require a cooperative endeavor of inspiring people with diverse expertise. I accept this recognition
on behalf of the team of co-inventors, students, and collaborators with whom new ideas have blossomed and discoveries have been made. I am also grateful to my university, region, and state, where
research and entrepreneurship are encouraged and supported.”
Dr. Ingrid Fritsch is a Professor in the Department of Chemistry and Biochemistry at the
University of Arkansas. She received a B.S. degree from the University of Utah and a Ph.D. from the
University of Illinois at Urbana-Champaign and was a postdoctoral associate at the Massachusetts
Institute of Technology. Fritsch has pioneered the field of redox-magnetohydrodynamic microfluidics and developed multifunctional miniaturized analytical devices and sensors, including protein and
DNA-hybridization microarrays interfaced to electrochemical detection. This work is important in
developing portable devices for environmental and point-of-care chemical analysis. She is the recipient of the 1997 Society of Electroanalytical Chemistry Young Investigator Award, a National Science
Foundation Career Award, an NSF Special Creativity Extension, and an American Chemical Society
Chemistry Ambassadorship. She holds ten issued U.S. patents (nine licensed), co-founded two
startup companies, and currently serves as a Member of the Board of Directors of SFC Fluidics, Inc.
(Fayetteville, AR).
Formerly from the department, Dr. Donald R. Bobbitt was
also named an NAI Fellow. He was awarded patents for discoveries he
made in the 1990s as a faculty member. Dr. Bobbitt now serves as
president of the University of Arkansas System. Both Fritsch and Bobbitt were recognized by the academy with a full-page announcement in
The Chronicle of Higher Education on January 16, and will appear in forthcoming issues of Inventors Digest and Technology and Innovation - Proceedings of the National Academy of Inventors.
According to the academy, election to NAI Fellow status is a
high professional distinction accorded to academic inventors who have
demonstrated a highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society.
To see the full article on the University of Arkansas Newswire, please go to http://bit.ly/1Lhtl0k
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Faculty News
On the Go

Chen, J.; Site-Selective Seeded
Growth of Bimetallic Nanostructures
and their Catalytic Applications, Department of Chemistry, Missouri State University, Springfield, MO, January 28,
2015; Brown University, February 5,
2015; University of Oklahoma, March6,
2015.

Publications

G.D. Keeler, J.M. Durdik, J.A.
Stenken, Localized Delivery of Dexamethasone-21-Phosphate via Microdialysis Implants in Rat Induces M(GC) Mac-

The Mole Street Journal
rophage Polarization and Alters CCL2
Concentrations, Acta Biomaterialia,
2015, 12, 11-20. DOI: 10.1016/
j.actbio.2014.10.022.
J.A. Stenken and A.J. Poschenrieder, Bioanalytical Chemistry of Cytokines - A Review, Analytica Chimica
Acta, 2015, 853, 95-115. doi:10.1016/
j.aca.2014.10.009.
Marion G. Götz, Hiroko
Takeuchi, Matthew J. Goldfogel, Julia
M. Warren, Brandon D. Fennell and
Colin D. Heyes. Visible-Light Photocatalyzed Cross-Linking of Diacetylene Ligands by Quantum Dots to
Improve Their Aqueous Colloidal Sta-

bility. J. Phys. Chem. B, (2014), 118,
14103-14109.
Lisunova, M.; Dunklin, J.R.; Jenkins, S.V.; Chen, J.; Roper, K.D.
The Unusual Visible Photothermal
Response of Free Standing Multilayered Films Based on Plasmonic
Bimetallic Nanocages, RSC Advances,
2015, DOI: 10.1039/C5RA00682A.
Jenkins, S.V.; Qu, H.; Mudalige,
T.; Ingle, T.; Wang, R.; Wang, R.;
Howard, P.C.; Chen, J.; Zhang, Y.
Rapid Determination of Plasmonic
Nanoparticle Agglomeration Status
in Blood, Biomaterials, 2015, accepted.

Technology Company TiFiberTM to Establish Production Facility in Fort Smith
TiFiber was formed in 2010 to commercialize a patented titanium dioxide based nanofiber membrane technology exclusively licensed from the University of Arkansas. TiFiber initially focused on photocatalytic membranes for water and air
filtration where there is great need for filtration improvement, especially in cases where high temperature sterilization is
required or where biofouling occurs rapidly. In 2013, the company expanded its intellectual property foundation by licensing an additional technology, a family of synthetic antimicrobial polymers, originally developed at the University of Auckland
(New Zealand). Initial applications being developed are for personal care products, wound care dressings, medical devices
and textiles. Products are currently in the research and development stage and discussions are underway with large, multinational companies for co-development of products.
On December 18, 2014, TiFiber, Inc. announced its plans to locate its pilot production facility and future company headquarters in Fort Smith, Arkansas to further develop and produce innovative new materials that safely and effectively control
dangerous microorganisms. Fort Smith was chosen not only because of its historic, strong support for manufacturing, but
also due to regional leaders’ efforts to attract leading edge, technology-based companies such as TiFiber.
In 2015, pilot-scale production will be established in order to support regulatory certification with the Food and Drug
Administration (FDA). Once TiFiber’s products have obtained regulatory approval, a full production facility will be established to provide AMP materials to manufacturers for inclusion into their products. It is anticipated that TiFiber’s Fort
Smith facility will begin significant production in 2017, and create up to 100 jobs by 2019.
Potential applications of TiFiber’s AMP technology include soaps, disposable and non-disposable medical plastics, dental
cements, wound care (acute and chronic wounds), medical devices (biofilm protection), cosmetic preservatives, and textiles. Initial development work has been supported by a combination of
private investment and economic development incentives from
the State of Arkansas. “TiFiber’s business outlook is very positive, as the company’s AMP technology meets urgent market
needs. The company is highly likely to create numerous science
and engineering jobs in Arkansas,” said Dr. Calvin Goforth, interim CEO of TiFiber. “We are very appreciative of financing and
tax credits received from the Arkansas Science and Technology
Authority, the Arkansas Development Finance Authority, and the
Arkansas Economic Development Commission, that are targeted
to help create these types of jobs in Arkansas, and which have
played a critical role in TiFiber’s launch and rapid progress.”
This article is an exerpt from PRWeb. The entire article can be
viewed at http://bit.ly/15PiE4t.

Dr. Mike Rutheford, TIFiber’s Chief Scientist, tests the efficacy of
the company’s novel antimicrobial polymers (AMPs), which have
proven highly effective against many dangerous microorganisms.
Mike received his Ph.D. in Chemistry from the University of Arkansas in 2010 under the direction of Professor Xiaogang Peng.

Volume 14, Issue 1

Page 3

From the Chair - Wesley Stites
It has been busy here in Fayetteville. Many of you are aware that several long time faculty members have or soon will retire. What you may not realize is how much work it is to hire a new faculty member and that is why January was a pretty exhausting month for the current faculty. I thought it might be interesting for our alumni and friends to know a bit more about
how we recruit and hire new faculty members.
First, in the summer of 2014 we were asked what our hiring wishes for the coming year were. We indicated that we expected two vacancies in August, 2015 and hoped for replacements and new hires to grow the faculty to keep pace with student
enrollment growth. Our replacement hires were approved, but we weren’t allowed to expand the faculty beyond the current
size, at least this year. Next, the faculty began a discussion about what areas in which to hire. This is based on many factors
including teaching needs, areas of research that seem likely to be fundable in the future, anticipated retirements, and available
space. Ultimately, we decided to look for new assistant professors in the areas of material chemistry and computational biophysics. As soon as advertisements and our recruiting plan were approved (a fairly slow process in the University bureaucracy), we placed ads and started prodding our contacts to find suitable candidates.
Over the next few months, dozens and dozens of applications streamed in, around a hundred for each position, along with
even larger numbers of recommendation letters. Even when the areas are narrowly defined as these were, many, many people
are interested in faculty positions at a major research university. Two committees were appointed from the faculty and did the
hard work of reading every cover letter, curriculum vita, research plan, teaching philosophy, and recommendation letter. They
found many great candidates. The hard part was deciding who among this stellar group to actually invite. After each committee had narrowed the applicants to a short list, the faculty as a whole reviewed those files and we collectively met, discussed
and voted on whom to interview. We invited four candidates for each position to visit us and present their past and proposed
research.
That meant sixteen seminars in just four weeks, hundreds of individual meetings, and lots of discussion. Again the hard part
was deciding between fantastic candidates. We voted and then waited again for approval to extend job offers to wind its way
through the bureaucratic process. After months and months of work we hope to soon introduce our newest faculty members.
Why so much care and thought? Every new faculty member is literally a multi-million dollar bet. A bet that the new person
will excel at teaching and research, funded this year by well over a million dollars in start-up costs and commitments to millions
more in salary and research space costs. And unlike a horse race, that bet will take years to see if we were right or wrong.
Our department has a great track record on placing good bets on new faculty, but with record growth in the student body and
an increasingly uncertain funding environment for chemical and biochemical research, the stakes have never been higher. Keep
your fingers crossed along with us that this year’s bets pay off.

Alumni News
James Beckman graduated in 1965 from U of A with a B.A. in Chemistry. As many of our students do, he continued on to medical school at UAMS, then residencies in general surgery and plastic & reconstructive surgery before returning to Fayetteville and plastic surgery practice 1980-2000.
Now retired from practice, he circled back to chemistry in some ways, as he is still very active as
director of R & D at Therapon Skin Health, a global skin care products company he founded in 1992.
From years of treating severely burned patients, he realized that there was a large need to restore mobility, suppleness, and softness to skin grafted hands so that patients could again bend fingers or grasp objects. No satisfactory skin treatment was available without prescription. His degree
in chemistry from the U of A and a passion for knowing the details of skin anatomy, physiology, and Dr. James Beckman, director of
R & D at Therapon
function led to searching hundreds of articles in the library.
This led to lab formulations with clinical testing to find the “ultimate skin restoration cream.” The vision was to create a
simplified method, a daily skin care system that would restore and rejuvenate aging skin to a beautiful, younger look. Research
led to several patents issued or pending. One patent was granted in 2013 for a nanoparticle, based on quantum physics properties, to “trap” 98% of UVA & UVB energy before it gets to the skin surface. Another patent pending stimulates apoptosis
(natural cell death) of malignant skin cancer cells when activated by halogen (visible) light rays. Ninety-eight percent (98%) plus
of human melanoma cells in living culture were killed in one hour exposure to ordinary halogen light. A third patent, now
pending, is for a method of reversing burn injury inflammatory events and symptoms.
The result was the Theraderm product family that restores sun-damaged or aged skin and produces youthful, natural beauty. It was a natural progression to start a company, Therapon (www.therapon.com) based here in NWA, to provide these new
products to other plastic surgeons and dermatologists for their patients.
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Upcoming Seminars

Dr. Toru Shiozaki, Assistant Professor at Northwestern University, will
present “Active Space Decomposition Theory for Excited States and Strongly Correlated Systems” on February 2 at 3:30 p.m.
in CHEM 144.

Dr. Stephan Link, Associate
Professor at Rice University, will
present “Collective Plasmon Modes
in Nanoparticle Assemblies” on February 15 at 3:30 p.m. in CHEM
144.

Dr. Song Jin, Professor, University of Wisconsin-Madison, will present “DislocationDriven Nanomaterial Growth and Solar Energy
Conversion using Earth-Abundant Nanomaterials” on March 9 at 3:30 p.m. in CHEM 144.

Dr. Xiadong Michael Shi, Associate Professor at West Virginia University, will present “Catalysis Based
on 1,2,3 Triazole Ligand: Chemistry Beyond ‘Click’” on February 23, at 3:30
p.m. in CHEM 144.

Dr. Elvin T. Price, Assistant
Professor, UAMS College of
Pharmacy, will present a seminar
March 16 at 3:30 p.m. in CHEM
144.

Mr. Les Johnson, Senior Technical
Advisor at RRD International, will
present a seminar March 30 at 3:30
p.m. in CHEM 144.

UA Chemistry Associate Professor Adams Recognized by The Protein Society
The National Organization for the Professional Advancement of Black Chemists and Chemical Engineers, NOBCChE (pronounced no-buh-shay), is an
organization that promotes careers in chemistry, chemical engineering, and
related fields as an achievable goal for minority students K-12. In addition,
NOBCChE encourages college students to pursue graduate degrees in STEM
disciplines. This year’s conference brought together renowned scientists and
talented young investigators for interactive and informative meetings in New
Orleans, LA. The Protein Society received an invitation to attend by Paul D.
Adams, Ph.D., who was selected as the 2013 NOBCChE President’s Award
for Excellence in STEM Research and Mentoring.
Associate Professor Paul Adams
The Protein Society Member E-News, December 2014

http://bit.ly/1A2hTm4

Stenken to Help Lead $375,000 Interdisciplinary Project
Professor Julie Stenken and Physics Assistant Professor Woodrow Shew were awarded $375,000 by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) to investigate the interplay of two
types of signaling in the brain. Under the grant, the investigators will develop new tools which - for the first time - will
measure changes in the electrical signals due to carefully controlled and measured changes in chemical signals within a
neuronal circuit. See the full Newswire article at http://bit.ly/1yUrcm6.
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The Cautionary Tale of Lysostaphin
Bringing a new drug to market is
risky business. Researchers thinking of
starting their own company should
enter with eyes-wide open and build a
solid business team to develop customers and human relationships needed for success. Even then, there are no
guarantees. An example of this is the tale of Lysostaphin.

A researcher's dream come true

Lysostaphin is an antimicrobial agent against Staphylococcus aureus, commonly referred as staph bacteria. A
company called Biosynexus Incorporated undertook the
commercialization of Lysostaphin and things started well.
Drug development was supported by an NIH-COBRE/
BRIN grant and partially funded by Biosynexus themselves.
In the early 2000's at the University of Arkansas, Dr. Jeff
Lu (now a senior staff scientist at ArmaGen Technologies)
solved the molecule structure's targeting domain as part of
his Ph.D thesis in Dr. Joshua Sakon’s lab (Lu et al. JBC
2006, 281:549).
This industry-university collaboration's success aided
the development of lysostaphin as a treatment option
against methicillin resistant S. aureus infection. The drug
quickly went through Phase I/II trials. A huge advancement
in the field at the right time.

A major equity event, the dream of every
start-up

In late 2002, Biosynexus teamed up with the pharmaceutical GlaxoSmithKline (GSK) (see http://bit.ly/18yGec).
For a start-up bio tech this was a huge coup – investors, a
major customer paying royalties, and manufacturing resources helped bring this drug to market. Then in 2005,
Biosynexus was bought by QVT Fund LP (see http://
bit.ly/1yQBdAF).

Broken dreams

I wish I could say that everyone involved stayed on
cloud 9. However by 2006, things were unraveling at the
seams. Biosynexus took GSK to court (and won) over
technology being transferred to a GSK sub-contractor/
competitor to Biosynexus. The case is somewhat complicated and if you’re a biotech CEO or founder, I recommend you read it to learn some industry insider practices
at http://bit.ly/15YPUHp.
Within a year, the QVT buyout went seriously wrong.
QVT refused to pay the Biosysnexus investors full amount,
claiming a whole host of faults, such as false representations of drug effectiveness and breached agreements with
a third-party license. And of course, the Biosysnexus investors counter sued. (See http://bit.ly/1DcfWRj). The
train wreck continued with the Biosysnexus investors later
suing the legal firm for legal failures in the contract writing
(see http://bit.ly/15YRmt9). It appears on the surface that
the Biosysnexus investors won every challenge, but at
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enormous cost and time. Again, if you’re a biotech CEO
or founder, I encourage you to read these sources for
industry insider practices.

What happened to Lysostaphin?

Well, I’m not completely sure. It seems that Lysostaphin gained a second-life at Bharat Biotech, a company
in India. Bharat bought the Lysostaphin patent in 2009
and their website says it is in Phase II trials (see http://
bit.ly/15YS4a0).
It is murky whether Bharat’s product is the same
product as Biosysnexus because research samples can be
produced easily and there are many scholar papers. My
guess is that Lysostaphin has become the grandmother of
a host of new drugs in the fight against Staphylococcus.

Four quick take-aways on Technology Commercialization

1) Startups are very risky and time consuming. And
tough, too! Sorry to say, but I have met more than
one academic that have problems accepting this.
The common statement I hear is: I have a patented
idea (like Lysostaphin) and people can’t do nothing’
without paying me. Sorry to say, but in reality, patents can be bypassed and the real value of an idea is
small until an end customer values it. This requires a
product go through applied research, Phase I, II, III
testing, and reliable manufacturing. Ask the folks at
Biosysnexus how difficult things can get.
2) Startups require a balanced, united, talented team;
each skilled in their area of expertise. I ask myself,
did the root of the legal problems stem from the
first GSK license not done right? Did Biosynexus
have the required level of legal and manufacturing
expertise? Getting the right people is a very difficult
thing to do as a start-up. Founders try to balance
the cost between people expertise and winning that
first big customer needed to keep the company going. This is a trade-off that keeps a CEO up at night.
I suggest starting early to find and build your team.
3) Quality of a person’s character matters more than
IQ or money. More questions: Why couldn’t QVT
and Biosynexus work things out? Did Biosynexus lie
during the buyout process? Did QVT try to squeeze
the smaller start-up? Both? All these questions go
back to the character of the people involved. It can
be tough to follow the spirit of the agreement.
4) Good tech lives on. Lysostaphin was picked up by
an ambitious company. Others see the potential and
are now carrying the load to provide the final benefits to society.
5) Good people live on. Although the original scientists/founders may not get financially rewarded, that
does not mean that they did not significantly contribute to helping society. Their learned skills can carry
their careers onward.
Written by Scott Weaver, principle consultant at Arise2, www.arise2consulting.com with significant contribution from Dr. Joshua Sakon.
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Student News
Science Building Renamed Discovery Hall
A little confusion now may prevent more confusion later. That is one
main reason why the Science Building (four letter building code SCIE) is
having its name changed to Discovery Hall (DISC). The Science Building
has served as the main home for teaching laboratories for both the Department of Chemistry and Biochemistry and the Department of Biological Sciences for about forty years. And, for much of that time students
have confused the Science Building with the nearby Science Engineering
Building.
“Homework assignments shoved under teaching lab doors, students wandering into offices in the first few weeks of class
looking for their lab; it happens every semester,” said Dr. Wesley Stites, chair of the chemistry and biochemistry department, “but when emergency services went to the wrong building twice in two weeks early this fall, that was too much. I
understand why the ambulance crews got confused, it confuses everyone. These two calls were for students with longterm medical conditions. Fortunately, no harm resulted from the delayed response, but I didn’t want to try our luck any
further after that.” A suggestion to change the name of the building was quickly approved.
Aside from safety and helping students quickly find the correct building, the name change also points out the investment
the University of Arkansas is making in teaching labs. Much of the biological sciences teaching labs will soon move into the
new Champions Hall on Dickson Street, across from Science Engineering. Major renovations in the Science Building have
been ongoing for years, renovations in the newly renamed Discovery Hall will continue, until in a few years when the entire building will effectively be new. The Department of Chemistry and Biochemistry will expand into space vacated by the
Department of Biological Sciences, and advanced biological science laboratories will continue to be taught in Discovery
Hall, but all spaces will be updated to meet current needs and modern laboratory standards. These departments will be
joined by the Department of Anthropology, which will move in fall 2015 from their current single, cramped teaching lab in
Kimpel Hall into three renovated labs in Discovery Hall.
The process of changing the name will take a while to be completed. Signs outside the building have already been changed,
but updating maps, information kiosks, and all the documents, and websites that refer to the Science Building will take longer. This will likely cause short-term confusion, but in the long-term the university hopes that Discovery Hall will be a name
that everyone understands marks its commitment to provide the best possible facilities to its students. And hopefully, nobody slides their homework assignment under the wrong door at 2:00 a.m. anymore.

Admitted to Candidacy
Dustin Baucom entered the
program in the fall of 2013. He
received his BS from Northeastern State University in
Tahlequah, OK. His advisor is
Colin Heyes.

Abdullah Qassab entered the
Cell and Molecular Biology program in the spring of 2013. He
received his BSc and MSc degrees
from Salahaddin University in Iraq.
His advisor is Wesley Stites.
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Ayinuola Receives Award

Impact Ministry with the Morrises

The Younger Chemists Committee (YCC) of the American Chemical Society has recognized
Kolawole Ayinuola as a recipient of
a Leadership Development Award to
support his participation in the YCC
Leadership Development Workshop.
The YCC program recognizes emerging leaders in the profession and helps
them prepare for the leadership opportunities at volunteer organizations,
such as ACS, and in their professional
careers. The workshop was held from Friday, January 23 to
Sunday, January 25, 2015, in conjunction with the ACS Leadership Institute in Dallas, Texas. During the workshop, participants engaged in discussions about the characteristics and
behaviors of effective leaders, identified leadership skills, developed a
person leadership development plan,
and learned about leadership opportunities within the American Chemical Society.

Jacqueline and
Scott Morris helped host
a Christmas party through
the Impact ministry at
Cross Church in Springdale. Says Jacqueline, “We
had over 100 kids, about
15 parents, and 20 volunteers. We taught a lesson
on the meaning of why we
celebrate Christmas, Jesus
Christ's birth. We had
pizza, desserts, and drinks
for every person. We did
crafts inside the townhouse our church owns, games outside for the boys, a
Girl Scout brought every child a hope box to show them
that they are loved by God, a goodie bag and stuffed animal for every kid. With the donated gifts we had a drawing for the 55 presents,
and a drawing for gift
cards for adults. Every
adult actually got a gift
card to either Subway
or Chick Fil A. It was
such a blessing to have
so many donated gifts
from David and Vicky
Hayes, David Paul,
Pooja Bajwa and
Marlena Patrick! The
weather was great too
so we got to be outside.
The volunteers were a
lot of college kids from
our church who just
wanted to help out on a Saturday :) such a huge success
and everyone had fun!”

7th Grade Science Students Visit the U of A
On Wednesday, November 19, 7th graders at The New
School in Fayetteville, AR visited the University of Arkansas
campus for demonstrations and a tour as part of an ongoing
collaboration between the Middle School at TNS, the U of A,
and Missouri University of Science and Technology, to enhance the science experience through “viral learning,” partially
supported by the National Science Foundation (NSF) and the
American Chemical Society (ACS). The purpose of this trip
was to acquaint Ms. Heather Overton’s 7th grade science
class at TNS with U of A science facilities and with graduate
and undergraduate students in the research laboratory of Dr.
Ingrid Fritsch. The 7th graders learned about probing brain
chemistry, energy storage and conversion by building potato
batteries, moving microscopic fluids with magnetism and electricity, weighing a single molecule, using X-rays and nuclear
magnetic resonance to determine the structure of molecules,
and the importance of laboratory safety. Other participants
were Willard Keirn and Jade Rundle from TNS, and Drs. Jim
Hinton, Bill Durham,
Katarzyna Janowska, and
students Ben Jones, Mengjia
Hu, Adam Kreidermacher,
Foysal Khan, and Corinne
Songer from the U of A.
Ph.D. graduate student Ben Jones
(middle) hosts the activity on energy
(building potato batteries) with TNS 7th
graders at the University of Arkansas.

Milestones
Marcus and Deepika (Talla)
Henze announce the birth
of their daughter, Arya
Henze, September 30,
2014. Deepika and family
live in the San Francisco
Bay area. The lure of Biotech industry brought them
there from Chicago in midOctober, 2014.

Excellence in the Central Science
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CHEM 119
1 University of Arkansas
Fayetteville, AR 72701
Phone: 479-575-4601
Fax: 479-575-4049
E-mail: cheminfo@uark.edu

We’re on the web!
chemistry.uark.edu
&
Department of Chemistry and
Biochemistry *University of
Arkansas

CUME Dates Announced

February
2
13
14
16
23

Seminar: Toru Shiozaki, Northwestern University,
3:30, CHEM 144
CUME - 5:00-6:00, CHEM 144
Valentine’s Day
Seminar: Stephan Link, Rice Univ., 3:30, CHEM 144
Seminar: Xiaodong Shi, West Virginia University,
3:30, CHEM 144

March
1
8
9
13
14
16
17
30

Application Deadline for students who plan to graduate at the end of Spring
Daylight Saving Time begins. Spring forward!
Seminar: Song Jin, Univ. of Wisconsin-Madison, 3:30,
CHEM 144
CUME - 5:00-6:00, CHEM 144
Pi Day - This year is special. Can you guess why?
Seminar: Elvin T. Price, UAMS College of Pharmacy,
3:30, CHEM 144
St. Patrick’s Day
Seminar: Les Eric Johnson, RRD International, 3:30,
CHEM 144

Spring CUME Dates:
January 23
February 13
March 13
April 3
April 24
5:00-6:00 p.m., CHEM 144

NOTICE: The Mole is moving to a
bi-monthly format. Our next publication will be at the first of April, and
will cover news that happens during
February and March. Please continue
to submit news articles in a timely
fashion each month.

Save the Date!

Safety Tip:

The 2015 INBRE conference
will be held November 6-7
in Fayetteville, AR.

by Bill Durham

Peroxides, azides and
perchlorates, in general,
should not be mixed
with any other waste.
There are others and
you should be mindful of
potentially reactive
combinations before
combining hazardous
waste.

The department of chemistry and biochemistry at the University of Arkansas strives for excellence in research, teaching and
service in chemistry - the central science. We aspire to positions of leadership regarding the discovery of new scientific
knowledge, the training of students, and the economic development of the State of Arkansas. We seek to recruit and retain a
diverse group of the best faculty, students and staff to address the challenges of the future through interdisciplinary and multidisciplinary research and education.

Library Hours

CHBC Library (CHEM 225)
http://libinfo.uark.edu/chemistry

Spring Semester Hours: January 11 - May 10
Regular Spring Hours
Saturday and Sunday
CLOSED
Monday – Thursday
8:00 am – 9:00 pm
Friday
8:00 am – 6:00 pm
Exceptions to Regular Spring Hours
Friday Mar 20
8:00 am - 5:00 pm
M-Th, Mar 23 -26 Spring Break
8:00 am - 5:00 pm
Friday Mar 27
Closed
Friday May 8
8:00 am - 5:00 pm
Intersession Hours: May 11 - 23
M-F
8:00 am - 5:00 pm
Saturday and Sunday
CLOSED
The chemistry and biochemistry library resources can be
accessed in the following LibGuides: http://uark.libguides.com/
content.php?pid=110953. Please bookmark for future use.

Department of Chemistry
and Biochemistry

Theses and dissertation resources can be found on the following
LibGuide: http://uark.libguides.com/content.php?pid=123035 &sid=1057466.

